IM Cannabis Corp. SEC filings IMCC
IM Cannabis Corp. has 302 filings in SEC EDGAR's recent list, going back to Oct 24, 2019. Its latest annual report, Form 20-F, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Mar 30, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2025 | Dec 31, 2024 |
| 20-F/A | Amended annual report (foreign issuer) | Sep 19, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 28, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 29, 2023 | Dec 31, 2022 |
| 40-F | Annual report (Canadian issuer) | Apr 4, 2022 | Dec 31, 2021 |
| 40-F/A | Amended annual report (Canadian issuer) | May 19, 2021 | Dec 31, 2020 |
| 40-F | Annual report (Canadian issuer) | Apr 26, 2021 | Dec 31, 2020 |
Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- IMCC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Central District, Israel
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1792030
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.